藥劑部首頁

電子處方集
處方集PDA版
中西藥交互作用查詢
健保給付規定
不良反應通報系統
意見信箱
PROPOFOL                                          仿單連結

點小圖看大圖

現行藥物外觀

中文名:飛可復2%注射劑

廠牌:FRESENIUS KABI /台灣費森尤

 

點小圖看大圖

 

中文名:飛可復2%注射劑

廠牌:FRESENIUS KABI /台灣費森尤

 

 

Product name
PROPOFOL 2%(50ML/BT)(FRESOFOL)
Dosage form
 
Indications
Anesthesia, general:ICU sedation: Monitored anesthesia care (MAC) sedation:
Administration & Dosage

Adult
Anesthesia, general:
Induction, titrate to 1-2.5 mg/kg in 20-40 mg increments every 10 sec until induction onset.
maintenance, 50-200μg/kg/min or 20-50 mg IV bolus(only for 1% Propofol); dose varies for age and surgery type.
ICU sedation:5 μg/kg/min for 5 mins then titrate to 5-50 μg/kg/min in 5-10 μg/kg/min increments; allow minimal of 5 mins between dose adjustments.
Monitored anesthesia care (MAC) sedation: initial 100-150 μg/kg/min or 0.5 mg/kg slow IV over 3-5 mins followed immediately by maintenance infusion 25-75 μg/kg/min or 10 mg or 20 mg incremental IV bolus doses( for 1% Propofol only) .

Pediatric
Anesthesia:
Induction: 3-16 yrs, 2.5-3.5 mg/kg IV over 20-30 sec;
Maintenance: 2 mo-16 yr, 125-300 μg/kg/min.

 
Contraindication
 
Precaution
 
Adverse reaction

M: Apnea; bradycardia; hypotension; involuntary muscle movements; N/V; irritancy at injection site
L or R: Hypertension; perioperative myoclonia; pancreatitis; abdominal cramping; cough; dizziness; fever; flushing; headache; hiccups; anaphylaxis; respiratory acidosis

 
Drug Interaction
 
Pregnancy Category
B
Notes
 
最近更新日期 2015年9月24日